These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19604118)

  • 1. Cladribine: not just another purine analogue?
    Spurgeon S; Yu M; Phillips JD; Epner EM
    Expert Opin Investig Drugs; 2009 Aug; 18(8):1169-81. PubMed ID: 19604118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cladribine].
    Ogura M
    Gan To Kagaku Ryoho; 2003 Feb; 30(2):309-17. PubMed ID: 12610885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cladribine. Ortho Biotech Inc.
    Tortorella C; Rovaris M; Filippi M
    Curr Opin Investig Drugs; 2001 Dec; 2(12):1751-6. PubMed ID: 11892941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cladribine: from the bench to the bedside--focus on hairy cell leukemia.
    Greyz N; Saven A
    Expert Rev Anticancer Ther; 2004 Oct; 4(5):745-57. PubMed ID: 15485311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-Chloro-2'-deoxyadenosine (2CdA) biochemical aspects of antileukemic efficacy.
    Fabianowska-Majewska K; Wyczechowska D
    Acta Pol Pharm; 1996; 53(4):231-9. PubMed ID: 9415193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cladribine for multiple sclerosis: review and current status.
    Sipe JC
    Expert Rev Neurother; 2005 Nov; 5(6):721-7. PubMed ID: 16274330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cladribine in indolent non-Hodgkin's lymphoma.
    Sigal DS; Saven A
    Expert Rev Anticancer Ther; 2008 Apr; 8(4):535-45. PubMed ID: 18402520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical pharmacology of 2-chlorodeoxyadenosine (Cladribine)].
    Góra-Tybor J; Robak T
    Przegl Lek; 1996; 53(8):614-8. PubMed ID: 8999463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspectives on purine analogues.
    Cheson BD
    Hematol Cell Ther; 1996 Dec; 38 Suppl 2():S109-16. PubMed ID: 9137964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cladribine for the treatment of hematologic malignancies.
    Baltz JK; Montello MJ
    Clin Pharm; 1993 Nov; 12(11):805-13; quiz 860-2. PubMed ID: 7903917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Older and new formulations of cladribine. Pharmacology and clinical efficacy in hematological malignancies.
    Robak T; Korycka A; Robak E
    Recent Pat Anticancer Drug Discov; 2006 Jan; 1(1):23-38. PubMed ID: 18221024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hairy cell leukemia: Part II: therapy with cladribine].
    Barth J; Rummel MJ
    Med Monatsschr Pharm; 2009 Jul; 32(7):252-60. PubMed ID: 19731753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cladribine for the treatment of hairy cell leukemia and chronic lymphocytic leukemia.
    Rai KR
    Semin Oncol; 1998 Jun; 25(3 Suppl 7):19-22. PubMed ID: 9671325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive proteomic analysis of the effects of purine analogs on human Raji B-cell lymphoma.
    Mactier S; Henrich S; Che Y; Kohnke PL; Christopherson RI
    J Proteome Res; 2011 Mar; 10(3):1030-42. PubMed ID: 21182289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse and beneficial immunological effects of purine nucleoside analogues.
    Dighiero G
    Hematol Cell Ther; 1996 Dec; 38 Suppl 2():S75-81. PubMed ID: 9137960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New purine analogues for the treatment of chronic B-cell malignancies.
    Gribbin TE
    Henry Ford Hosp Med J; 1991; 39(2):98-102. PubMed ID: 1679757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine).
    Füreder W; Weltermann A; Chott A; Gisslinger H; Valent P; Jäger U; Geissler K; Lechner K
    Wien Klin Wochenschr; 1999 Dec; 111(24):1027-30. PubMed ID: 10677889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of purine nucleoside analogues.
    Plunkett W; Gandhi V
    Hematol Cell Ther; 1996 Dec; 38 Suppl 2():S67-74. PubMed ID: 9137959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cladribine conundrum: deciphering the drug's mechanism of action.
    Hentosh P; Peffley DM
    Expert Opin Drug Metab Toxicol; 2010 Jan; 6(1):75-81. PubMed ID: 19968576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond hairy cell: the activity of cladribine in other hematologic malignancies.
    Sigal DS; Miller HJ; Schram ED; Saven A
    Blood; 2010 Oct; 116(16):2884-96. PubMed ID: 20634380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.